The advantages of TCM in the treatment of gynecologic malignancies
Authors:
Open Access
- 5 September 2025
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 15, 1570732
Abstract
Gynecological malignancies are characterized by high morbidity and mortality rates. With the development of society, the status of women continues to improve, yet the social pressure they bear increases daily. The incidence rate of gynecological malignancies in the female population has always remained at a high level, and the age of onset has shown a trend of getting younger. Common gynecological malignancies include cervical cancer, ovarian cancer, and endometrial cancer. Alarmingly, over 70% of patients are diagnosed at an advanced stage. This disease is mainly treated through surgery and radiotherapy, but there is still a relatively high recurrence rate after treatment. In recent years, with the development of traditional Chinese medicine (TCM), the advantages of TCM in the treatment of gynecological malignancies have gradually emerged. The entry of TCM into the treatment of Gynecologic malignancies is a tumor treatment method that has received close attention from the international medical community in recent times. TCM can be used throughout the whole process of tumor treatment. Combining Western medicine at different stages of the tumor, or giving different Chinese medicines alone, can minimize the toxic side effects of Western medicine treatment, alleviate symptoms, prolong survival and improve the quality of survival. Therefore, combining traditional Chinese medicine to provide individualized treatment for patients may become a better approach to cancer treatment. This article reviews the status and important role of TCM in gynecological malignancies in the hope of exploring new treatment modalities to mitigate the impact of gynecological malignancies on women’s health.Keywords
This publication has 100 references indexed in Scilit:
- Advances in cervical cancer: current insights and future directionsCancer Communications, 2024
- Traditional Chinese medicine in human diseases treatment: New insights of their potential mechanismsThe Anatomical Record, 2023
- Progress in surgical oncology: Gynecology perspectiveJournal of Surgical Oncology, 2022
- Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancerCochrane Database of Systematic Reviews, 2022
- Treatment times in breast cancer patients receiving neoadjuvant vs adjuvant chemotherapy: Is efficiency a benefit of preoperative chemotherapy?Cancer Medicine, 2020
- Ovarian cancer: Current status and strategies for improving therapeutic outcomesCancer Medicine, 2019
- Advances in ovarian cancer therapyCancer Chemotherapy and Pharmacology, 2017
- Longitudinal perceptions of the side effects of chemotherapy in patients with gynecological cancerSupportive Care in Cancer, 2017
- First-in-human phase II trial of the botanical formulation PHY906 with capecitabine as second-line therapy in patients with advanced pancreatic cancerCancer Chemotherapy and Pharmacology, 2013
- Preventive effect of a traditional herbal medicine, Hochu-ekki-to, on immunosuppression induced by surgical stressSurgery Today, 2008